{
    "organizations": [],
    "uuid": "52b38919b7ba8dbff846d3540f7759378f2d98fa",
    "author": "",
    "url": "https://www.reuters.com/article/brief-adaptimmune-therapeutics-reports-q/brief-adaptimmune-therapeutics-reports-quarterly-loss-per-ordinary-share-of-0-05-idUSASC09SE9",
    "ord_in_thread": 0,
    "title": "BRIEF-Adaptimmune Therapeutics Reports Quarterly Loss Per Ordinary Share Of $0.05",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 15, 2018 / 11:40 AM / Updated 25 minutes ago BRIEF-Adaptimmune Therapeutics Reports Quarterly Loss Per Ordinary Share Of $0.05 Reuters Staff March 15 (Reuters) - Adaptimmune Therapeutics Plc: * ADAPTIMMUNE REPORTS FOURTH QUARTER / FULL YEAR 2017 FINANCIAL RESULTS AND BUSINESS UPDATE * ADAPTIMMUNE THERAPEUTICS PLC QUARTERLY LOSS PER ORDINARY SHARE $0.05 * ADAPTIMMUNE THERAPEUTICS - BELIEVES EXISTING CASH AND CASH EQUIVALENTS, SHORT-TERM DEPOSITS TO FUND CURRENT OPERATING PLAN THROUGH TO EARLY 2020 * ADAPTIMMUNE THERAPEUTICS PLC QUARTERLY REVENUE $4.3 MILLION VERSUS $8.5 MILLION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)",
    "published": "2018-03-15T13:38:00.000+02:00",
    "crawled": "2018-03-15T14:11:34.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "report",
        "quarterly",
        "loss",
        "per",
        "ordinary",
        "share",
        "reuters",
        "staff",
        "march",
        "reuters",
        "adaptimmune",
        "therapeutic",
        "plc",
        "adaptimmune",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "business",
        "update",
        "adaptimmune",
        "therapeutic",
        "plc",
        "quarterly",
        "loss",
        "per",
        "ordinary",
        "share",
        "adaptimmune",
        "therapeutic",
        "belief",
        "existing",
        "cash",
        "cash",
        "equivalent",
        "deposit",
        "fund",
        "current",
        "operating",
        "plan",
        "early",
        "adaptimmune",
        "therapeutic",
        "plc",
        "quarterly",
        "revenue",
        "million",
        "versus",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}